Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2010

01.06.2010 | Invited Commentary

Discussion: immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications

verfasst von: Amy K. Alderman, Reshma Jagsi

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Excerpt

Dr. Cowen and co-authors should be commended for their efforts to describe patterns and correlates of complications after mastectomy with immediate tissue expander/implant reconstruction and adjuvant post-mastectomy radiotherapy. It is important for clinicians to understand the outcomes and predictors of successful breast reconstruction among patients receiving radiotherapy. Post-mastectomy radiation therapy is now considered to be an integral component of cancer treatment for many patients. Radiation therapy is associated with a two-thirds reduction in the relative risk of loco-regional failure and a survival benefit in appropriately selected patients [1]. However, radiation is not without its risks. Several retrospective studies have suggested that radiation increases the risk of post-operative complications in patients with expander/implant reconstructions [2]. Therefore, understanding the risk factors for post-operative complications in the setting of reconstruction and radiation will help to improve the informed consent process and assist clinicians and patients alike with treatment decision-making. …
Literatur
1.
Zurück zum Zitat Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 366(9503):2087–2106PubMed Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 366(9503):2087–2106PubMed
2.
Zurück zum Zitat Spear SL, Onyewu C (2000) Staged breast reconstruction with saline-filled implants in the irradiated breast: recent trends and therapeutic implications. Plast Reconstr Surg 105(3):930–942CrossRefPubMed Spear SL, Onyewu C (2000) Staged breast reconstruction with saline-filled implants in the irradiated breast: recent trends and therapeutic implications. Plast Reconstr Surg 105(3):930–942CrossRefPubMed
3.
Zurück zum Zitat Del Pozo JL, Tran NV, Petty PM et al (2009) Pilot study of association of bacteria on breast implants with capsular contracture. J Clin Microbiol 47(5):1333–1337CrossRefPubMed Del Pozo JL, Tran NV, Petty PM et al (2009) Pilot study of association of bacteria on breast implants with capsular contracture. J Clin Microbiol 47(5):1333–1337CrossRefPubMed
4.
Zurück zum Zitat Adams WP Jr (2009) Capsular contracture: what is it? What causes it? How can it be prevented and managed? Clin Plast Surg 36(1):119–126 Adams WP Jr (2009) Capsular contracture: what is it? What causes it? How can it be prevented and managed? Clin Plast Surg 36(1):119–126
5.
Zurück zum Zitat Wong C-H, Samuel M, Tan B-K, Song C (2006) Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg 118(5):1224–1236CrossRefPubMed Wong C-H, Samuel M, Tan B-K, Song C (2006) Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg 118(5):1224–1236CrossRefPubMed
6.
Zurück zum Zitat Barnsley GP, Sigurdson LJ, Barnsley SE (2006) Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: a meta-analysis of randomized controlled trials. Plast Reconstr Surg 117(7):2182–2190CrossRefPubMed Barnsley GP, Sigurdson LJ, Barnsley SE (2006) Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: a meta-analysis of randomized controlled trials. Plast Reconstr Surg 117(7):2182–2190CrossRefPubMed
7.
Zurück zum Zitat Ceilley E, Jagsi R, Goldberg S et al (2005) Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys 61(2):365–373PubMed Ceilley E, Jagsi R, Goldberg S et al (2005) Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys 61(2):365–373PubMed
8.
Zurück zum Zitat Alderman AK, Wilkins E, Kim M, Lowery J (2002) Complications in post-mastectomy breast reconstruction: two year results of the Michigan breast reconstruction outcome study. Plast Reconstr Surg 109:2265–2274CrossRefPubMed Alderman AK, Wilkins E, Kim M, Lowery J (2002) Complications in post-mastectomy breast reconstruction: two year results of the Michigan breast reconstruction outcome study. Plast Reconstr Surg 109:2265–2274CrossRefPubMed
9.
Zurück zum Zitat Gylbert L, Asplund O, Jurell G (1990) Capsular contracture after breast reconstruction with silicone-gel and saline-filled implants: a 6-year follow-up. Plast Reconstr Surg 85(3):373–377CrossRefPubMed Gylbert L, Asplund O, Jurell G (1990) Capsular contracture after breast reconstruction with silicone-gel and saline-filled implants: a 6-year follow-up. Plast Reconstr Surg 85(3):373–377CrossRefPubMed
11.
Zurück zum Zitat Bindra RR, Dias JJ, Heras-Palau C et al (2003) Assessing outcome after hand surgery: the current state. J Hand Surg 28(4):289–294 Bindra RR, Dias JJ, Heras-Palau C et al (2003) Assessing outcome after hand surgery: the current state. J Hand Surg 28(4):289–294
12.
Zurück zum Zitat Pusic AL, Reavey PL, Klassen AF et al (2009) Measuring patient outcomes in breast augmentation: introducing the BREAST-Q augmentation module. Clin Plast Surg 36(1):23–32CrossRefPubMed Pusic AL, Reavey PL, Klassen AF et al (2009) Measuring patient outcomes in breast augmentation: introducing the BREAST-Q augmentation module. Clin Plast Surg 36(1):23–32CrossRefPubMed
13.
Zurück zum Zitat Likert R (1932) A technique for the measurement of attitudes. Arch Psychol 140:1–55 Likert R (1932) A technique for the measurement of attitudes. Arch Psychol 140:1–55
14.
Zurück zum Zitat Hu ES, Pusic AL, Waljee JF et al (2009) Patient-reported aesthetic satisfaction with breast reconstruction during the long-term survivorship period. Plast Reconstr Surg 124(1):1–8CrossRefPubMed Hu ES, Pusic AL, Waljee JF et al (2009) Patient-reported aesthetic satisfaction with breast reconstruction during the long-term survivorship period. Plast Reconstr Surg 124(1):1–8CrossRefPubMed
15.
Zurück zum Zitat Alderman AK, Wilkins E, Lowery J et al (2000) Determinants of patient satisfaction in post-mastectomy breast reconstruction. Plast Reconstr Surg 106:769–776CrossRefPubMed Alderman AK, Wilkins E, Lowery J et al (2000) Determinants of patient satisfaction in post-mastectomy breast reconstruction. Plast Reconstr Surg 106:769–776CrossRefPubMed
Metadaten
Titel
Discussion: immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications
verfasst von
Amy K. Alderman
Reshma Jagsi
Publikationsdatum
01.06.2010
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2010
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-0878-z

Weitere Artikel der Ausgabe 3/2010

Breast Cancer Research and Treatment 3/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.